The clinical diagnosis of malformations of cortical development (MCDs) is often challenging due to the complexity of the brain malformation by neuroimaging, the rarity of individual malformation syndromes, and the rapidly evolving genetic landscape of these disorders facilitated with the use of Next Generation Sequencing (NGS) methods.
| INTRODUCTION
With the advent of Next Generation Sequencing (NGS) methods, a growing number of genes are being identified in association with a wide spectrum of complex developmental brain disorders (Barkovich, Guerrini, Kuzniecky, Jackson, & Dobyns, 2012) . The diagnosis of severe cortical malformations, such as classic lissencephaly, is often achievable clinically by the identification of characteristic neuroimaging abnormalities, which facilitates a more targeted molecular testing strategy (Guerrini & Dobyns, 2014) . However, more complex cortical malformations continue to pose challenges from a diagnostic perspective due to variability of the neuroimaging features of the brain malformation, and/ or rarity of individual types of malformations. Examples of such malformations include polymicrogyria (PMG), variable types of pachygyria, and more subtle forms of cortical dysplasia. The KIF5C gene was identified recently in 2013 as a rare cause of cortical malformations variably characterized by regional or focal pachygyria with or without microcephaly, with only four children identified to have mutations of this four previously reported individuals, we show that mutations of this gene are associated with a distinctive neurodevelopmental syndrome characterized by infantile-onset epilepsy and subtle but distinctive brain malformations typically recognizable by high-quality neuroimaging.
| MATERIALS AND METHODS

Patients were enrolled in the Developmental Brain Disorders Research
Program at the Seattle Children's Research Institute, with IRB approval.
The investigators reviewed all clinical, neuroimaging, and molecular data. Molecular analysis was performed through clinically available targeted next generation commercial panels consisting of >1,000 genes associated with epilepsy, intellectual disability, and autism using the Agilent Clinical Research Exome kit. Sequencing was performed using the Illumina sequencing system with 2 × 100 bp paired-end reads.
| RESULTS
The neuroimaging and clinical features of our two patients, along with the previously published KIF5C mutation-positive individuals, are summarized in Table 1 .
| Patient 1 (LR16-416)
This boy was born to consanguineous (first cousin) parents of Pakistani ancestry. He was born full-term via vaginal delivery following an uncomplicated pregnancy and labor. Birth weight was 3.03 kg (25-50th percentile for age and gender). He is the eldest of three siblings (a girl and two boys). The proband presented with poor feeding initially requiring nasogastric tube supplementation, global developmental delays, and diffuse hypotonia. He had seizure-like events at age one month characterized by head drop, generalized body stiffness, and widening of the eyes lasting a few seconds to one minute. Multiple electroencephalograms (EEGs) performed between 15 months and 12 years of age showed multifocal abnormalities mainly consisting of spike and waves discharges. With the use of antiepileptic medications, he had partial seizure control until age 3 years and became free of overt clinical seizures allowing for steady, slow developmental progress from age 3 to 12 years. Other medical issues included bilateral congenital hip dysplasia surgically corrected with bilateral femoral varus osteotomies, and left Dega innominate osteotomy complicated by Superior Mesenteric Artery Syndrome.
On last assessment at age 13 years, seizures were well controlled. His weight was 40.2 kg (20th percentile), length was 152.9 cm (25th percentile), and occipito-frontal circumference (OFC) was 53.2 cm (10-25th percentile). Facial examination revealed a few subtle dysmorphic features including synophrys, laterally prominent ears, prominent nasal bridge, and a relatively large mouth (Figures 1a and 1b) . Spinal examination revealed scoliosis. Neurological examination showed a delayed non-verbal boy with limited mobility (using a wheelchair). He was unable to walk independently, but stood for short periods of time with the use of a gait trainer. Fine motor skills were delayed with inability to hold objects. He was non-verbal and exhibited several stereotypic movements including teeth grinding, thumb sucking, rocking behavior, and repetitive hand movements. He frequently smiled and made appropriate eye contact, but did not follow commands. He had increased oral secretions and dysphagia requiring a liquid diet. He was enrolled in special education in 7th grade, primarily consisting of physical, occupation, speech, and functional therapy multiple times per week.
Brain magnetic resonance imaging (MRI) at age 1 and 3 years showed several abnormalities including subtle irregularity of the cortical gray-white matter junction suggestive of dysgyria, with a thick cortex in the frontal, parietal lobes, and perisylvian regions (thickness ∼9.9 mm).
Other abnormalities include mildly thin corpus callosum (genu, body, and splenium), mild ventriculomegaly, and mildly small cerebellar vermis with subtle foliar dysplasia (Figures 1c and 1d ). The patient underwent multiple genetic and metabolic tests, which were inconclusive. Testing for epilepsy genes through a targeted NGS panel of 1,148 genes (GeneDx EpiXpanded panel) identified a de novo heterozygous mutation in KIF5C (NM_004522.2, c. 709G>A, p.Glu237Lys).
| Patient 2 (LR17-160)
This girl is of Vietnamese non-consanguineous ancestry. She was born full-term via vaginal delivery following an uncomplicated pregnancy.
Birth weight was 3.34 kg (25-50th percentile). She is the youngest child of two healthy siblings (a girl and a boy). At age 3 months, she presented with global developmental delays, spasticity, and apparent microcephaly. On examination, further signs included eye fixation, constipation, and a red, scaly rash covering her cheeks, scalp, arms, legs, and trunk. Early onset epilepsy occurred at 3 months, with seizures being predominantly febrile. At age 6 months, she developed afebrile seizures including staring spells. She has continued to have seizures since, and has been on and off oxcarbazepine since age 6 years. An awake EEG at age 13 months was normal.
On last assessment at age 11 years, growth measurements were as follows: weight was 30.4 kg (10th percentile), length was 145 cm (44th percentile), and OFC was 49 cm (3.5 standard deviations below the mean).
Facial examination revealed a few subtle dysmorphic facial features including low sloping forehead, apparent prognathism, relatively large mouth with downturned corners, mildly arched eyebrows, and mildly higharched palate (Figures 1e and 1f) . Neurological examination showed a delayed non-verbal girl. She could independently ambulate but her gait was unsteady and mildly wide-based. She had axial and appendicular hypotonia. She did not have a pincer grasp, did not point, and required assistance with all self-care skills. Her speech and language development were severely delayed as well, with increased oral secretions. She was nonverbal with limited social skills. She also had several behavioral problems include self-injurious behavior, aggression, impulsivity, and pica. She was receiving Applied Behavior Analysis (ABA) therapy in addition to physical therapy and speech therapy at her elementary school. Other medical issues included persistent nocturnal enuresis. She had a tonsillectomy and adenoidectomy at 5 years of age due to obstructive sleep apnea.
Brain MRI at age 10 months showed cortical dysgyria in the frontal and mesio-frontal regions with undersulcation and simplification of the gyral pattern, thin and mildly dysplastic corpus callosum, mild Table S1 ). Our data, combined with the literature, establish that mutations of KIF5C cause a neurodevelopmental disorder characterized by infantile-onset epilepsy, neurobehavioral issues including absent speech/language development, and a distinctive spectrum of brain malformations (Table 1) .
The six KIF5C mutation-positive individuals, including the two published in this report, all had cortical brain malformations that can be conservatively classified as a cortical dysplasia (or dysgyria), and ranged in appearance from a thick to disorganized microgyric cortex, suggestive of pachygyria, or polymicrogyria, respectively; although the quality of the imaging data was suboptimal for some of the previously reported individuals to fully assess the appearance of the cortical gyral pattern. Importantly, the pattern of distribution of the cortical dysplasia in KIF5C mutation-positive children is distinctive as it appears to be frontal (including mesio-frontal) in five out of the six reported individuals. Interestingly, these five individuals all had mutations involving amino acid Glu237, with four individuals harboring the same p.Glu237Lys mutation. The cortical gyral pattern in one previously reported individual was distinct with a posterior-(rather than anterior-) predominant distribution, under-sulcation of the cortex, and a thick subcortical band heterotopia (SBH) (Jamuar et al., 2014) . This individual had a different mutation downstream of Glu237 (p.Ala268Ser). These data suggest that KIF5C mutations involving amino acid Glu237 may be associated with a more consistent phenotype than other mutations, with possible preliminary genotype-phenotype correlations (Table 1) .
In a few reported patients, the cortical dysplasia was overall mild (Poirier et al., 2013) , and in some patients, the cortical gyral pattern appeared irregular with possible microgyri suggestive of PMG. Both patients reported in our study had mild cortical dysplasia involving predominantly the frontal and mesio-frontal regions (Figure 1 ). Other notable MRI features in all six KIF5C mutation-positive children include mild ventriculomegaly (seen in 5/6 patients), a thin and dysplastic corpus callosum (5/6 patients), and cerebellar abnormalities (seen only in patient LR16-416 who had mild cerebellar vermis hypoplasia with subtle foliar dysplasia). Furthermore, one previously-reported patient had a single periventricular nodular heterotopia (Cavallin et al., 2016) .
Therefore, the key features of KIF5C related disorders, to date, appear to include the following: (1) cortical malformation variably classified as dysplasia that can resemble pachygyria or PMG, with simplification of the gyral pattern, (seen in 6/6 patients), and a characteristic pattern of distribution that is anterior-predominant, including frontal and mesio-frontal in individuals with mutations of Glu237; (2) variable other brain MRI features including callosal and cerebellar abnormalities that can be subtle or mild (seen in 5/6 patients); (3) early infantile onset epilepsy (seen in 4/6 patients);
(4) severe intellectual disability with absent speech and language development (seen in 4/6 patients); and (5) abnormal stereotypic movements along with several neurobehavioral issues including aggression and self-injurious behavior (seen in 3/6 patients).
The Glu237Lys mutation identified in our two patients is located within the microtubule-binding domain of the gene and, therefore, appears to be highly recurrent (Cavallin et al., 2016) . The p.Glu237Lys mutation has been identified to be de novo in four individuals, with no sibling recurrence. The fifth KIF5C mutation-positive family consisted of four affected individuals (all boys) who had cortical dysplasia and microcephaly, with limited imaging data as three boys died in utero.
These siblings had a different substitution at the same amino acid position in KIF5C, p.Glu237Val, presumed to be due to maternal germline mosaicism (Poirier et al., 2013) . The sixth patient had a distinct de novo mutation (p.Ala268Ser) that also lies within the microtubule-binding domain. (Jamuar et al., 2014) . As mentioned previously, the distribution of the cortical malformation of this patient was also distinct from the other mutation-positive children as it was posterior-, rather than anterior-, predominant in distribution with SBH. Therefore, all in all, the molecular spectrum of KIF5C related disorders appears to be narrow with a recurrent mutation affecting amino acid Glu237, and with all mutations clustered within the microtubule binding domain of the protein. Mutations of KIF5C have been shown to cause Kinesin proteins to lose their ability to hydrolyze ATP and lead to a non-functional motor domain (Padzik et al., 2016) .
Mutations of the amino acid Glu237 have been shown to affect the binding ability of these microtubule proteins to their targets, protein folding and ATP hydrolysis (Cavallin et al., 2016; Poirier et al., 2013) .
In summary, we report the fifth and sixth children with KIF5C mutation, to date. Both individuals presented with a distinctive clinical picture characterized by frontal predominant cortical dysplasia, with subtler callosal, cerebellar and ventricular abnormalities. Our study adds to the previous limited literature on KIF5C related disorders and establishes that this spectrum constitutes a severe neurodevelopmental disorder characterized by variable brain malformations, early onset epilepsy, absent language and speech development, and neurobehavioral issues. Clinical and neuroimaging recognition of these features, along with the narrow mutational spectrum of KIF5C related disorders to date, will facilitate more efficient clinical and molecular diagnosis of affected individuals in the future.
